Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesOptimal timing of radical cystectomy for patients with T1 bladder cancer
Urologic Oncology: Seminars and Original Investigations, 07/01/09
Bochner BH - Radical cystectomy for T1 disease is associated with an excellent survival; however, the optimal timing of radical cystectomy remains one of the more difficult clinical dilemmas in the management of patients with bladder cancer. This article reviews the various features associated with an increased risk of disease progression to provide a framework for optimizing the timing of radical cystectomy.
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09
Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Article Search
Sponsor